Published in Ann Clin Biochem on March 01, 2006
Gastric acid hypersecretory states: recent insights and advances. Curr Gastroenterol Rep (2009) 0.87
Diagnosis of Zollinger-Ellison syndrome: increasingly difficult. World J Gastroenterol (2012) 0.85
Surgical treatment of gastrinomas: a single-centre experience. HPB (Oxford) (2012) 0.83
The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis. Exp Mol Pathol (2012) 0.83
Primary hepatic gastrinoma: an unusual case of zollinger-ellison syndrome. Gastroenterol Hepatol (N Y) (2010) 0.82
Serum concentrations of gastrin after famotidine and omeprazole administration to dogs. J Vet Intern Med (2014) 0.81
Pharmacotherapy of Zollinger-Ellison syndrome. Expert Opin Pharmacother (2013) 0.81
Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest (2014) 0.78
A Perplexing Case of Abdominal Pain That Led to the Diagnosis of Zollinger-Ellison Syndrome. Case Rep Gastrointest Med (2017) 0.75
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Virulent foot rot in sheep. Vet Rec (1997) 5.14
Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters. Bioconjug Chem (1995) 3.90
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature (2000) 2.85
Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut (2003) 2.64
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Ovine footrot. Vet Rec (1999) 2.14
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90
International disease surveillance. Vet Rec (2004) 1.68
Exploiting the DNA repair defect in BRCA mutant cells in the design of new therapeutic strategies for cancer. Cold Spring Harb Symp Quant Biol (2005) 1.67
Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health (1995) 1.66
A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging (2012) 1.62
Changing disease patterns in AIDS. BMJ (1991) 1.59
Peptide-specific antibodies as probes of the orientation of the glucose transporter in the human erythrocyte membrane. J Biol Chem (1987) 1.57
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
The clinical characteristics of headache in patients with pituitary tumours. Brain (2005) 1.44
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int J Obes (Lond) (2006) 1.28
Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol (1992) 1.27
Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects. Eur J Clin Nutr (2011) 1.27
Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett (1990) 1.25
Neuroendocrine tumours. Endocr Relat Cancer (2004) 1.21
A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet (1998) 1.18
Deformational mass transport and invasive processes in soil evolution. Science (1992) 1.14
Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett (1997) 1.13
Regulation of hepatic enzymes and insulin levels in offspring of rat dams fed a reduced-protein diet. Am J Physiol (1997) 1.08
Current approaches to the management of ovine footrot. Vet J (2005) 1.04
Lipoma or liposarcoma? A cautionary case report. J Plast Reconstr Aesthet Surg (2011) 1.03
Laparoscopic management of insulinomas. Br J Surg (2009) 1.02
Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology (1997) 0.99
Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med (2013) 0.99
A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet (2003) 0.97
Immunoglobulin patterns in keratoconus with particular reference to total and specific IgE levels. Br J Ophthalmol (1982) 0.97
Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment? Ann Clin Biochem (2002) 0.97
Gut hormones: a weight off your mind. J Neuroendocrinol (2008) 0.95
Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol (Oxf) (2002) 0.94
Cutaneous aspects of Refsum's disease. J R Soc Med (1991) 0.94
In vivo modulation of human lymphocyte Fc gamma-receptors in response to oral antigen (cows' milk) challenge. Int Arch Allergy Appl Immunol (1982) 0.94
Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int J Obes (Lond) (2013) 0.90
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. J Clin Endocrinol Metab (2002) 0.90
Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects. Clin Sci (Lond) (1998) 0.89
Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem. Br J Pharmacol (2013) 0.89
Do time trends in food supply levels of macronutrients reflect survey estimates of macronutrient intake? Am J Public Health (1992) 0.89
Adrenal incidentaloma in familial adenomatous polyposis: a long-term follow-up study and schema for management. Dis Colon Rectum (2009) 0.89
The physiology of the endocrine system. Int Anesthesiol Clin (1997) 0.88
Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic--pituitary--adrenal axis. Eur J Endocrinol (2002) 0.88
Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab (2006) 0.86
Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology (2001) 0.85
Black hair follicular dysplasia in UK bred salukis. Vet Rec (1995) 0.85
Characterisation of monoclonal antibodies which specifically recognise the human erythrocyte glucose transport protein. EMBO J (1985) 0.84
Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1. J Neuroendocrinol (2003) 0.84
Restriction endonuclease profiles of orf virus isolates from the British Isles. Vet Rec (1998) 0.83
Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trial. J Clin Endocrinol Metab (2012) 0.83
Effects of keratinocyte growth factor (KGF) on gut growth and repair. J Pathol (1998) 0.83
Low TSH in a patient with primary hypothyroidism. J R Soc Med (2005) 0.82
The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinoma. Eur Radiol (2009) 0.82
Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations. Br J Cancer (2012) 0.82
Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin. Xenobiotica (1980) 0.81
Hypokalaemia in acute Refsum's disease. J R Soc Med (1993) 0.81
External exposure to radionuclides accumulated in shoreline sediments with an application to the lower Clinch River. Health Phys (2000) 0.81
Lewis phenotypes, insulin resistance, and risk of ischaemic heart disease. Br Heart J (1994) 0.80
Pituitary carcinoma as a cause of acromegaly. N Engl J Med (2001) 0.80
Agouti related protein (AgRP) is upregulated in Cushing's syndrome. Exp Clin Endocrinol Diabetes (2005) 0.79
The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours. Pituitary (2004) 0.79
Microinjection of galanin-like peptide into the medial preoptic area stimulates food intake in adult male rats. J Neuroendocrinol (2006) 0.79
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci U S A (1997) 0.79
Sudden death in lambs associated with Clostridium sordellii infection. Vet Rec (1996) 0.79
Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effect. Regul Pept (1998) 0.79
Reduction of vasoconstriction mediated by neuropeptide Y Y2 receptors in arterioles of the guinea-pig small intestine. Br J Pharmacol (1995) 0.78
Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration? Regul Pept (2000) 0.78
The tumour vanishes. Clin Endocrinol (Oxf) (2000) 0.78
The effects of ciliary neurotrophic factor on the hypothalamo-pituitary gonadal axis in vitro in female rats. J Neuroendocrinol (2000) 0.78
High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy. Clin Endocrinol (Oxf) (2008) 0.78
The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Clin Endocrinol (Oxf) (2011) 0.78
Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors. Endocrinology (1996) 0.78
A high pressure x-ray photoelectron spectroscopy study of CO oxidation over Rh(100). J Phys Condens Matter (2013) 0.78
Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol (2000) 0.77
Weight loss in rats treated with intracerebroventricular cobalt protoporphyrin is not specific to the neuropeptide Y system. Brain Res (1996) 0.77
Islet cell tumours: diagnosis and medical management. Hosp Med (2000) 0.77
Peripheral arterial compliance is lower in Afro-Caribbeans compared to white Caucasians with type 2 diabetes after adjustment for blood pressure. J Hum Hypertens (1999) 0.77
Octreotide is not effective in the acute treatment of migraine. Cephalalgia (2005) 0.77
The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int (1994) 0.77
Oro-facial granulomatosis and clinical atopy. J Oral Med (1986) 0.77
Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients. Clin Endocrinol (Oxf) (2008) 0.76
Measurement of total and specific IgE levels in the management of a family exhibiting a high incidence of keratoconus. Acta Ophthalmol (Copenh) (1984) 0.76
No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours. Acta Neurol Scand (2005) 0.76
Acromegaly: a unique human headache model. Headache (2003) 0.76
The relationship between neuropeptide Y expression and headache in pituitary tumours. Eur J Neurol (2006) 0.76
The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism. Regul Pept (1998) 0.76
Contagious ovine digital dermatitis. Vet Rec (2003) 0.75
Surveillance for scrapie. Vet Rec (2000) 0.75
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 0.75